Creative Medical Technology Holdings Inc (CELZ)

[monte379]

I would agree that things have been glacial, especially for the OTC. And as I have opined, I think one reason was leaving the old centrifugal procedure behind for the new process. But that only explains the last quarter of 2018. I still think, and will always think this way until proven otherwise, that a ton is going on behind the scenes and it is bearing fruit now. Anyway, I think the blunted parts is fair too. What they tell us they tell their competition.